Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sch1-Quintessentially English

5 Sep 2006 12:13

AIM05 September 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Quintessentially English PLC COMPANY ADDRESS:235 Old Marylebone Road, London COMPANY POSTCODE:NW1 5QT COUNTRY OF INCORPORATION:United Kingdom COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BEDISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:Manufacture and sale of in vitro medical diagnostic kits DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issueprice to which it seeks admission and the number and type to be held as treasury shares):121,776,865 ordinary shares of 1p each CAPITAL TO BE RAISED ON ADMISSION:£1,000,000 FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Michael Stephen Gurner (Chairman)Robert Michael Coe (Finance Director)*Graham Basil Ashley (Non-Executive Director)* * to resign on Completion of the Acquisition Proposed DirectorsAndrew William Shepherd (Proposed Chief Executive Officer)Kieron Antony Harbonson (Proposed Finance Director and Company Secretary)David Eric Evans (Proposed Non-Executive Director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUEDSHARE CAPITAL BEFORE AND AFTER ADMISSION: Name Number of Percentage of Number of Percentage of Ordinary Shares Ordinary Shares Ordinary Shares Ordinary Shares Pre Admission Pre Admission on Admission on AdmissionM S Gurner 3,666,866 32.81 3,666,866 3.01R M Coe 1,666,666 14.91 1,666,666 1.37G B Ashley 1,333,333 11.93 1,333,333 1.09A W Shepherd - - 32,102,756 26.36Scottish Enterprise - - 18,130,081 14.89Ms J A Monks Shepherd - - 8,811,809 7.24 NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THEAIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:31 March EXPECTED ADMISSION DATE:19 September 2006 NAME AND ADDRESS OF NOMINATED ADVISER:City Financial Associates Limited, Pountney Hill House, 6 Laurence Pountney Hill, London EC4R 0BL NAME AND ADDRESS OF BROKER:Seymour Pierce Ellis Limited, Talisman House, Jubilee Walk, Three Bridges, Crawley, West Susssex RH101LQ DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH ASTATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:Copies of the admission document, which contains full details about Quintessentially English PLC andthe admission of its securities to AIM, will be available from the offices of City FinancialAssociates Limited, Pountney Hill House, 6 Laurence Pountney Hill, London EC4R 0BL, until one monthafter admission. DATE OF NOTIFICATION:4 September 2006 NEW / UPDATE (see note):New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Mar 20217:00 amRNSContract with Screen4
24th Feb 20217:00 amRNSUK-RTC statement on AbC-19TM rapid antibody test
19th Feb 20211:45 pmRNSDirector/PDMR Shareholding
18th Feb 202110:00 amRNSDirector/PDMR Shareholding
16th Feb 20217:00 amRNSAbC-19TM rapid antibody test performance data
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:01 amRNSUK Government contract and trading update
11th Feb 20217:00 amRNSDirectorate Change
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSStatement re Media Comment
2nd Feb 20218:45 amRNSExercise of Options and Total Voting Rights
28th Jan 20211:15 pmRNSExercise of Options and Total Voting Rights
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20217:02 amRNSLab-based COVID-19 antibody test service launch
26th Jan 20217:01 amRNSUpdate re AbC-19 Rapid Test
25th Jan 202111:06 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
22nd Jan 202110:15 amRNSExercise of Options and Total Voting Rights
22nd Jan 20219:05 amRNSSecond Price Monitoring Extn
22nd Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 202111:00 amRNSExercise of Options and Total Voting Rights
29th Dec 20207:01 amRNSUpdate re AbC-19 Rapid Test
29th Dec 20207:00 amRNSAbC-19TM Rapid Test Update
24th Dec 202012:41 pmRNSSecond Price Monitoring Extn
24th Dec 202012:35 pmRNSPrice Monitoring Extension
24th Dec 202012:00 pmRNSMologic CE Mark Rapid Antigen Test
24th Dec 202011:05 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
11th Dec 20202:05 pmRNSSecond Price Monitoring Extn
11th Dec 20202:00 pmRNSPrice Monitoring Extension
11th Dec 20209:45 amRNSExercise of Options and Total Voting Rights
7th Dec 20208:00 amRNSExercise of Options and Total Voting Rights
2nd Dec 20209:00 amRNSDirector/PDMR Shareholding
30th Nov 20202:30 pmRNSExercise of Options and Total Voting Rights
30th Nov 20207:00 amRNSInterim Results
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 20209:45 amRNSExercise of Options and Total Voting Rights
17th Nov 20207:45 amRNSUK-RTC Update
16th Nov 20207:16 amRNSHolding(s) in Company
16th Nov 20207:15 amRNSHolding(s) in Company
13th Nov 20202:05 pmRNSSecond Price Monitoring Extn
13th Nov 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20209:30 amRNSExercise of Options and Total Voting Rights
12th Nov 20203:42 pmRNSUK-RTC Statement
12th Nov 202011:05 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.